Novartis AG (NVS)
NVSNYSEBiotechnology: Pharmaceutical Preparations
$163.55
-0.1400 (-0.09%) today
Regular session, Nov 10, 2:25 PM ET
- Market cap
- $312.08bn
- P/E
- 18.4
- EPS, last 4 quarters
- $8.89
- Dividend yield
- –
- Day range
- $162.38 to $164.18
- 52-week range
- $123.24 to $170.46
- Average volume
- 1.76m
- Previous close
- $163.69
Analysts
4 coveringHold2 buy, 2 hold, 0 sell
Targets a year out average $159.67, -2.4% from here
Earnings
next estimate $2.23Next report
Dec 2025
+2.0%
Mar 2026
-5.7%
Jun 2026
+9.6%
Sep 2026
+9.3%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Novartis' Ianalumab Shows Continued Benefits In Two-Year Sjögren's Study RTTNews · 24 minutes ago
- Zacks Industry Outlook Highlights Eli Lilly, Novartis and BayerZacks · 13 hours ago
- 3 Large-Cap Stocks to Watch as Drug & Biotech Sector Rebounds in 2026Zacks · 1 day ago
- FDA Investigates Cancer Risk Associated With Novartis' Zolgensma Gene Therapy RTTNews · 3 days ago
- Weekly Buzz: RDY, LUPIN, SUNPHARMA Score FDA Wins; AGIO, RARE Slash Jobs; CVS Plots Split RTTNews · 4 days ago
- Novartis: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 7 days ago
- BioArtic's BrainTransporter Collaboration With Novartis Ends Following Program Discontinuation RTTNews · Nov 3, 2026
- 3 Stocks to Watch Following Guidance UpgradesZacks · Nov 2, 2026
The company
is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide.Reimagine medicine with us: Visit us at https://www.novartis.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- Europe
- Website
- novartis.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.